ICD-10-CM Billable Code

I70.769

Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, unspecified extremity

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code I70.769 refers to a condition known as atherosclerosis affecting other types of bypass grafts in the extremities, which has led to gangrene in an unspecified limb. This condition is a serious health concern that involves the blockage of blood flow caused by the buildup of fatty deposits within the arteries of the bypass grafts, leading to tissue death or gangrene.

Causes & Symptoms

Clinical Causes: Progressive buildup of fatty deposits (atherosclerosis) within the bypass grafts. Poor blood circulation due to narrowed or blocked grafts. Inadequate blood supply to the extremities causing tissue damage. Factors that contribute to atherosclerosis such as high cholesterol, smoking, diabetes, and hypertension.

Key Symptoms: Discoloration of the affected limb, often dark or black indicating necrosis. Severe pain or numbness in the affected area. Swelling and tenderness around the graft site. Presence of ulcers or open sores that do not heal. Coldness or numbness in the fingers or toes. Foul smell from gangrenous tissue in advanced cases.

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of clinical examination and diagnostic tests, including:

Treatment Protocols: Treatment options focus on restoring blood flow, managing infection, and preventing further tissue damage, often involving:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is I70.769 a billable ICD-10 code?
Yes, I70.769 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report I70.769?
Clinical documentation must specify the nature of Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, unspecified extremity and any associated comorbidities for accurate reporting.

Cite this Clinical Reference